Genome Canada Annual Report 2016-17 21 • Emerging issues – Genome Canada contributed toward a $713,100 research project to study the pathology of the Zika virus – a public health emergency of international concern. The data gener- ated through this project, based at the University of Saskatchewan, will provide tools to assess new ways to treat and prevent the spread of the virus. In addition to these new investments, Genome Canada continued its support of several other ongoing large-scale science projects, and other international and na- tional initiatives. Some projects started wrapping up during the fiscal year. These included some funded through the 2012 Bioinformatics and Computational Biology Competition. We also provided operational support to 10 technology platforms across the coun- try. The platforms not only offer the services needed to undertake research, but also pro- vide advice on appropriate technologies, study design, data analysis and bioinfor- matics. Their services are available to the entire research community across Canada. • 2015 Large-Scale Applied Research Project Competition – Natural Resources and the Environment: Sector Challenges – Genomic Solutions – Genome Canada and co-funding partners are investing $110 million over four years in 13 large-scale applied research projects focused on using genomics to address challenges and opportunities of importance to Canada’s natural resources and environmental sectors, including interactions between natural resources and the environment. The projects will empower Canada to address the climate change challenge, strengthen the bioeconomy and increase Canadians’ wellbeing. • 2015 Bioinformatics and Computational Biology Competition – Genome Canada, in partnership with the Canadian Institutes of Health Research, is supporting 16 projects with a $4-million investment. The projects will produce next-generation tools and methodologies to deal with the influx of large amounts of data produced by modern genomics technologies, and will provide the research com- munity with broad access to these tools. • 2015 Disruptive Innovation in Genomics Competition – Genome Canada is investing in transformative genomics-based technologies and ideas to tackle some of Canada’s toughest challenges, create new market opportunities and spur job growth. Genome Canada is investing $5 million in 20 projects at the idea phase (Phase 1). An additional $13.3 million is being invested by Genome Canada and co-funding partners in five projects at the prototype phase (Phase 2). Funding was announced and flowed to a number of large- scale science and leading-edge technology projects during the 2016-17 fiscal year to fuel innovation in Canada. INVEST